Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2007

Published online before print March 8, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow Supplemental Data
Right arrow All Versions of this Article:
jlb.0606400v1
81/6/1599    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzi, M.
Right arrow Articles by Tobler, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzi, M.
Right arrow Articles by Tobler, A.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0606400


Received for publication June 14, 2006.
Revised December 23, 2006.
Accepted for publication January 24, 2007.


Article

The death-associated protein kinase 2 (DAPK2) is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells

Mattia Rizzi *, Mario P. Tschan *@, Christian Britschgi *, Adrian Britschgi *, Barbara Hügli *, Tobias J. Grob *, Nicolas Leupin *, Beatrice U. Mueller {dagger}, Hans-Uwe Simon {ddagger}, Andrew Ziemiecki {sect}, Bruce E. Torbett ||, Martin F. Fey , and Andreas Tobler **

*Experimental Oncology/Hematology, Medical Oncology, and **Hematology, Inselspital, and {sect}The Tiefenau Laboratories, Department of Clinical Research, and Departments of {dagger}Internal Medicine and {ddagger}Pharmacology, University of Bern, Bern, Switzerland; and ||Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA

@ To whom correspondence should be addressed. E-mail: mtschan{at}dkf.unibe.ch.


   Abstract

The death-associated protein kinase 2 (DAPK2) belongs to a family of Ca2+/calmodulin-regulated serine/threonine kinases involved in apoptosis. During investigation of candidate genes operative in granulopoiesis, we identified DAPK2 as highly expressed. Subsequent investigations demonstrated particularly high DAPK2 expression in normal granulocytes compared with monocytes/macrophages and CD34+ progenitor cells. Moreover, significantly increased DAPK2 mRNA levels were seen when cord blood CD34+ cells were induced to differentiate toward neutrophils in tissue culture. In addition, all-trans retinoic acid (ATRA)-induced neutrophil differentiation of two leukemic cell lines, NB4 and U937, revealed significantly higher DAPK2 mRNA expression paralleled by protein induction. In contrast, during differentiation of CD34+ and U937 cells toward monocytes/macrophages, DAPK2 mRNA levels remained low. In primary leukemia, low expression of DAPK2 was seen in acute myeloid leukemia samples, whereas chronic myeloid leukemia samples in chronic phase showed intermediate expression levels. Lentiviral vector-mediated expression of DAPK2 in NB4 cells enhanced, whereas small interfering RNA-mediated DAPK2 knockdown reduced ATRA-induced granulocytic differentiation, as evidenced by morphology and neutrophil stage-specific maturation genes, such as CD11b, G-CSF receptor, C/EBP{varepsilon}, and lactoferrin. In summary, our findings implicate a role for DAPK2 in granulocyte maturation.

Key Words: DRP-1 • AML • myelopoiesis




This article has been cited by other articles:


Home page
BloodHome page
J. Fang, M. Menon, D. Zhang, B. Torbett, L. Oxburgh, M. Tschan, E. Houde, and D. M. Wojchowski
Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2
Blood, August 1, 2008; 112(3): 886 - 890.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Luxen, S. A. Belinsky, and U. G. Knaus
Silencing of DUOX NADPH Oxidases by Promoter Hypermethylation in Lung Cancer
Cancer Res., February 15, 2008; 68(4): 1037 - 1045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.